A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1997
10/09/1997	WO1997030150A3 Molecules for the induction of immunological tolerance
10/09/1997	WO1997030146A3 Cardiotrophin and uses therefor
10/09/1997	WO1997030088A3 Methods of treating vascular disease with tnf antagonists
10/09/1997	WO1997026912A3 Anti-cd18 antibodies for use against stroke
10/09/1997	WO1997021820A3 A novel protein kinase required for ras signal transduction
10/09/1997	DE19613933A1 Cyclische Adhäsionsinhibitoren Cyclic adhesion inhibitors
10/09/1997	DE19613691A1 Arzneimittel für die Behandlung von Tumorerkrankungen Drugs for the treatment of tumor diseases
10/09/1997	DE19613406A1 Expression von HGV-Antigenen und deren Verwendung Expression of HGV antigens and their use
10/09/1997	CA2260808A1 Method of restoring a functional protein in a tissue by cell transplantation
10/09/1997	CA2259133A1 High molecular weight surface proteins of non-typeable haemophilus
10/09/1997	CA2250938A1 Laminin 5 for growth of pancreatic islet cells
10/09/1997	CA2250866A1 Identification and isolation of novel polypeptides having ww domains and methods of using same
10/09/1997	CA2250857A1 Asymmetric hammerhead ribozymes
10/09/1997	CA2250849A1 Novel cyclin-selective ubiquitin carrier polypeptides
10/09/1997	CA2250829A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997	CA2250826A1 Protein phosphatase-1 catalytic subunit interactions
10/09/1997	CA2250814A1 Cyclic peptide vaccines for treatment and prevention of diabetes
10/09/1997	CA2250702A1 Active survival domains of igf-ir and methods of use
10/09/1997	CA2250269A1 Human natural killer cell activating factor ii
10/09/1997	CA2250232A1 A method of treating cancer
10/09/1997	CA2250129A1 Candida albicans tata-binding protein, nucleic acid and assays
10/09/1997	CA2250121A1 Tfiib transcription factor from candida albicans
10/09/1997	CA2250110A1 Growth differentiation factor-14
10/09/1997	CA2249716A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/09/1997	CA2249459A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors
10/09/1997	CA2249369A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/09/1997	CA2249349A1 Design of novel highly efficient hiv based packaging systems for gene therapy
10/09/1997	CA2249206A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997	CA2248985A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
10/09/1997	CA2248856A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
10/09/1997	CA2248729A1 Promotion of regeneration of organized tissues
10/09/1997	CA2248550A1 Cytokine designated lerk-8
10/09/1997	CA2222596A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/08/1997	EP0799893A1 Defective viral particles obtained in vivo or ex vivo as vaccine
10/08/1997	EP0799891A1 Anti-Fas recombinant antibodies and DNA therefor
10/08/1997	EP0799890A2 Recombinant inactive core streptavidin mutants
10/08/1997	EP0799889A1 Mammalian potassium channel family, their cloning and their use for drug screening
10/08/1997	EP0799873A1 Composition for a non-wettable coating, process for treating glazing pane with this composition and the products obtained
10/08/1997	EP0799836A1 Novel monoclonal antibody having inhibitory effect on type ii phospholipase a2 and protein containing a part of the same
10/08/1997	EP0799620A1 Cyclosporin emulsions
10/08/1997	EP0799577A1 Peptide mixture and products thereof
10/08/1997	EP0799315A2 Telomerase protein component
10/08/1997	EP0799311A1 Human chemokine beta-9
10/08/1997	EP0799310A1 Production of recombinant secretory component
10/08/1997	EP0799309A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
10/08/1997	EP0799308A1 Tissue specific hypoxia regulated therapeutic constructs
10/08/1997	EP0799243A1 p53 PROTEINS WITH ALTERED TETRAMERIZATION DOMAINS
10/08/1997	EP0799242A1 Amphiphilic complexes, method for preparing same and compositions containing such complexes
10/08/1997	EP0799241A1 Peptides having immunomodulatory activity
10/08/1997	EP0799240A1 Heterocyclic keto arginine peptides as thrombin inhibitors
10/08/1997	EP0799058A1 Improvements in or relating to endometrial function
10/08/1997	EP0799052A1 New antithrombotic formulation, process for its manufacturing, and use thereof
10/08/1997	EP0799051A2 Irrigation solution and method for inhibition of pain, inflammation and spasm
10/08/1997	EP0799030A1 Powder formulations containing melezitose as a diluent
10/08/1997	EP0799027A1 Liposomal interferon hybrid compositions
10/08/1997	EP0798971A1 Increasing creatine and glycogen concentration in muscle
10/08/1997	EP0629212B1 New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
10/08/1997	EP0580782B1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/08/1997	EP0482089B1 Method of treating autoimmune uveoretinitis in human
10/08/1997	CN1161714A Human chemokine beta-9
10/08/1997	CN1161698A Cyclic hexapeptide somatostatin analogues
10/08/1997	CN1161652A Pharmaceutical compositions
10/08/1997	CN1161648A Methods for maintaining teeth and oral bone
10/08/1997	CN1161376A Streptokinase genes and the separation and express thereof
10/07/1997	US5675062 Mouse engrafted with histoincompatible artery which exhibits detectable arteriosclerosis with in 30 days of grafting
10/07/1997	US5675060 Expression of transgene results in mouse having chronic inflammation and deformation of synovial joints; for determining antiarthritic potentials of compositions
10/07/1997	US5674995 Oligonucleotides specific for cytokine signal transducer gp130 mRNA
10/07/1997	US5674994 Polynucleotides encoding the anti-PEM antibody BW835 variable domains and expression vectors
10/07/1997	US5674982 Multimeric form of human rhinovirus receptor protein
10/07/1997	US5674981 Human calcitonin receptor polypeptides
10/07/1997	US5674980 Fusion protein comprising tat-derived transport moiety
10/07/1997	US5674978 Peptides derived from glutamic acid decarboxylase
10/07/1997	US5674977 Branched synthetic peptide conjugate
10/07/1997	US5674976 Coupling first modular component to third modular component to yield precyclized gamma turn mimetic, cyclizing
10/07/1997	US5674905 Administering as gastrin or cholecystokinin antagonists
10/07/1997	US5674898 Methods and therapeutic compositions for treating cystic fibrosis
10/07/1997	US5674896 Triglycerides having stearic acid residue at 2-position and other fatty acid residues containing two to ten carbons at the 1- and 3-positions, for mixing with foods or replacing other fat or oils
10/07/1997	US5674890 Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them
10/07/1997	US5674882 Retroviral protease inhibiting compounds
10/07/1997	US5674855 Intravenously administering protein- and peptide-free mixture containing cholanic acid or salt and a phospholipid
10/07/1997	US5674850 High purity desmopressin produced in large single batches
10/07/1997	US5674849 Antiviral oligopeptide and acyclovir, ganciclovir, penciclovir, famciclovir, azidothymidine, dideoxycytidine, dideoxyinosine, or 2'-deoxy-3'-thiacytidine
10/07/1997	US5674848 Bioreactor compositions with enhanced cell binding
10/07/1997	US5674846 Having paralytic effect on larvae of tobacco budworm, heliothis virescens
10/07/1997	US5674845 Administering insulin-like growth factor(somatomedins)
10/07/1997	US5674844 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
10/07/1997	US5674843 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor β
10/07/1997	US5674842 Growth inhibitory peptide
10/07/1997	US5674841 Method for inhibiting growth of stem cells
10/07/1997	US5674840 Synthetic aglucodalbaheptide antibiotics
10/07/1997	US5674839 Cyclic analogs of alpha-MSH fragments
10/07/1997	US5674838 Cleavaged hirudin at amino acid position 36-37 or 63-64, linkaged with a polyether, amino compound or mono- or polysaccharides; anticoagulants
10/07/1997	US5674836 Hypertensive agents
10/07/1997	US5674835 Papillomaviral expression inhibitors
10/07/1997	US5674834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
10/07/1997	US5674748 Human cyclin-dependent kinase-like proteins and methods of using the same
10/07/1997	US5674739 Human gene FOHY030 coding for tumor progression inhibitor
10/07/1997	US5674734 Cell death protein
10/07/1997	US5674725 Fibrillar collagen biocompatible carrier
10/07/1997	US5674722 Genetic modification of endothelial cells

1 ... 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 ... 3163